JERUSALEM, ISRAEL--(Marketwired - Sep 17, 2015) -  Intec Pharma Ltd . (the "Company") (NASDAQ: NTEC) (TASE: INTC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced that the underwriters of its